DelveInsight's Rheumatoid Arthritis Market Insights report includes a comprehensive understanding of current treatment practices, rheumatoid arthritis emerging drugs, market share of individual ...

The Michigan Supreme Court will decide in the coming months whether to overturn nearly two decades of precedent to clear the way for an attorney general investigation ...

A once-daily oral nonpeptide GLP-1 conferred significant improvements in body weight, HbA1c and other cardiometabolic ...

· Eli Lilly and Company announced it is building the most powerful supercomputer owned and operated by a pharmaceutical ...

Michigan Attorney General Dana Nessel's office is asking the court to overturn two previous rulings and allow an investigation into Eli Lilly and Co.

The office of Michigan’s attorney general on Wednesday again urged the state Supreme Court to overturn two prior rulings that it says hamstring its desire to investigate Eli Lilly & Co.’s insulin ...

Pfizer and Novo Nordisk seem to want Metsera bad. Analysts are wondering, though: is the obesity biotech really worth this much effort?

Last year, China-based Jiangsu Hengrui Pharmaceuticals overtook the U.K.’s AstraZeneca as the top clinical trial sponsor in ...

Discover how Novo Nordisk's pipeline is being restructured to refocus its efforts on high-growth areas like diabetes and ...

The bank's lead analyst recognizes the importance of getting in early with potentially game-changing drug development.

The results send a ‘clear, pragmatic message’ of IL-17 inhibition’s greater potency over IL-12/23 inhibition, an expert says.

Eli Lilly has pulled out of the central nervous system (CNS)-focused portion of a $960 million biobucks deal centered on ...